Anacapa Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Anacapa Technologies's estimated annual revenue is currently $6.4M per year.
- Anacapa Technologies's estimated revenue per employee is $155,000
Employee Data
- Anacapa Technologies has 41 Employees.
- Anacapa Technologies grew their employee count by -5% last year.
Anacapa Technologies's People
Name | Title | Email/Phone |
---|
Anacapa Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Anacapa Technologies?
Anacapa Technologies, Inc. is a market leader and innovator in the formulation of broad spectrum antimicrobial wound care products. Anasept® Antimicrobial Skin & Wound Cleanser and Gel is a powerful board-spectrum, topical antimicrobial that is long-acting, crystal clear and highly-viscous, available in a tube as a hydrogel or as a liquid in spray and pour bottles. What will Anasept® treat? • Anasept® Antimicrobial Skin & Wound Gel is a long-acting thick hydrogel indicated for the management of partial to full thickness wounds, pressure ulcers, diabetic foot ulcers, surgical incisions, first and second degree burns, donor, and graft sites. • Anasept® Antimicrobial Skin & Wound Cleanser (liquid & spray) is used for general antiseptic site preparation for central line, graft-fistula cannulation and wound cleansing and debridement. • There is no known resistance to Anasept®. Anasept® quickly kills infection causing bacteria (including MRSA, VRE, C. difficile), C. difficile spores, pathogenic fungi, Hepatitis and HIV. • Anasept® is unmatched in eliminating the foulest orders • Anasept® is also known to assist with the effective debridement of necrotic slough and bio-debris due to its unique molecular action.
keywords:N/AN/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.5M | 41 | 3% | N/A |
#2 | $9.5M | 41 | -7% | N/A |
#3 | $8.2M | 45 | -4% | N/A |
#4 | $10.7M | 46 | 7% | N/A |
#5 | $8.6M | 55 | 8% | N/A |